Bone Biologics Corporatio...

NASDAQ: BBLGW · Real-Time Price · USD
8.02
-2.77 (-25.67%)
At close: Aug 15, 2025, 2:36 PM
9.11
13.59%
After-hours: Aug 15, 2025, 04:00 PM EDT

Bone Biologics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-4.22M -9.43M -3.67M -1.1M
Interest Income
55.66K 1.87K 731.71 805.11
Pretax Income
-7.33M -8.95M -1.49M -1.61M
Net Income
-4.11M -8.95M -1.49M -1.61M
Selling & General & Admin
2.09M 2.52M 2.09M 1.02M
Research & Development
2.13M 6.91M 1.58M 82.04K
Other Expenses
n/a n/a n/a -44
Operating Expenses
4.22M 9.43M 3.67M 1.1M
Interest Expense
n/a n/a 731.71K 805.11K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
4.22M 9.43M 3.67M 1.1M
Income Tax Expense
n/a n/a n/a 1.6K
Shares Outstanding (Basic)
1.52M 263.14K 47.6K 43K
Shares Outstanding (Diluted)
1.52M 263.14K 47.66K 43.13K
EPS (Basic)
-4.83 -34.01 -31.15 -37.35
EPS (Diluted)
-4.83 -34.01 -31.2 -37.35
EBITDA
-4.11M 479.57K -4.4M -1.1M
EBIT
-4.11M -8.95M -3.67M -805.58K
Depreciation & Amortization
n/a 9.43M 3.67M 1.1M